• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD MAX¿ MRSA XT; SYSTEM, NUCLEIC ACID AMPLIFICATION TEST, DNA, METHICILLIN RESISTANT STAPHYLOCOCC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD MAX¿ MRSA XT; SYSTEM, NUCLEIC ACID AMPLIFICATION TEST, DNA, METHICILLIN RESISTANT STAPHYLOCOCC Back to Search Results
Catalog Number 443461
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/25/2023
Event Type  malfunction  
Manufacturer Narrative
B3: date of event is unknown.B3.The date received by manufacturer has been used for this field.H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd max¿ mrsa xt a sample that was negative came back positive via pcr.The following information was provided by the initial reporter: during verification of mrsa xt test on bd max, we have a sample that was negative in mrsa xt and also in our comparison method easyplex mrsa (amplex).According to culture, it was an mrsa (already known).We sent sample to the partner laboratory for mrsa-pcr: positive there.(b)(4).
 
Manufacturer Narrative
Event date was update from 7/31/2023 to 7/25/2023.There for b.2 was updated to the correct date.H.6 investigation summary the complaint investigation for discrepant results when using the bd max¿ mrsa xt kit (ref.443461) from unknown lot # was performed by the verification of complaints history.Customer reported that during verification, one sample gave a mrsa negative result with the bd max¿ mrsa xt assay as well as with another method (easyplex® mrsa, amplex) but it gave a mrsa positive result when analyzed by pcr by another laboratory as well as in culture.Despite multiple attempts made to receive information from the customer, no kit lot number nor data was provided for the investigation.Without data, bd is unable to identify the cause of the customer issue.As mentioned in the package insert, the bd max¿ mrsa xt assay is designed to detect mrej genotypes i, ii, iii, iv, v, vi, vii, ix, xiii, xiv, and xxi which represent most of meca and mecc harboring mrsa strains (belonging to different sccmec/mrej types) accounting for more than 98% of worldwide strains tested by bd to date.It must be noted that sccmec and mrej typing are different typing methods, without any link between them.The investigation suggests that the customer strain may correspond to a mrej type undetected by the bd max¿ mrsa xt assay.Without analysis of the customer strain, bd was unable to confirm the customer issue.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on the bd max¿ mrsa xt assay products.The root cause was not identified.Bd acknowledge the customer issue but cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa) since no new hazard was identified.Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.H3 other text : see h.10.
 
Event Description
It was reported that while using bd max¿ mrsa xt a sample that was negative came back positive via pcr.The following information was provided by the initial reporter: during verification of mrsa xt test on bd max, we have a sample that was negative in mrsa xt and also in our comparison method easyplex mrsa (amplex).According to culture, it was an mrsa (already known).We sent sample to the partner laboratory for mrsa-pcr: positive there.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ MRSA XT
Type of Device
SYSTEM, NUCLEIC ACID AMPLIFICATION TEST, DNA, METHICILLIN RESISTANT STAPHYLOCOCC
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17591881
MDR Text Key321693567
Report Number1119779-2023-00915
Device Sequence Number1
Product Code NQX
UDI-Device Identifier00382904434618
UDI-Public00382904434618
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K133605
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number443461
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-